If Kirpa is on the money then I would be more than happy with $21.00. As this is a total game changer and has a world wide use there will be an absolute premium paid. Don't forget there were some really promising initial results with fatty liver so this med tech is multi faceted which is good news for shareholders.
EMvision Research Notes, page-2264
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.00 |
Change
0.090(4.71%) |
Mkt cap ! $170.8M | |||
| Open | High | Low | Value | Volume |
| $1.98 | $2.00 | $1.95 | $41.09K | 20.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $1.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.00 | 561 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.00 |
Change
0.090 ( 3.05 %) |
||||
| Open | High | Low | Volume | ||
| $1.98 | $2.00 | $1.95 | 7083 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| EMV (ASX) Chart |
